REQUEST A DEMO
Total
USD $0.00
Search more companies

Empire Pharma Polska Sp. z o.o. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Administrative Management and General Management Consulting Services
Full name: Empire Pharma Polska Sp. z o.o. Profile Updated: June 12, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Empire Pharma Polska Sp. z o.o. is a company based in Poland, with its head office in Wolomin. It operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers industry. The company was established on April 22, 2020. In its most recent financial highlights, the company reported a net sales revenue drop of 20.14% in 2024. Its’ total assets recorded a negative growth of 96.63%. The net profit margin of Empire Pharma Polska Sp. z o.o. decreased by 13.92% in 2024.

Headquarters
Ul. Poniatowskiego 53B
Wolomin; Mazowieckie; Postal Code: 05-200

Contact Details: Purchase the Empire Pharma Polska Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Empire Pharma Polska Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Empire Pharma Polska Sp. z o.o. report to view the information.
Incorporation Date:
April 22, 2020
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
99%
Company Performance
Financial values in the chart are available after Empire Pharma Polska Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-20.14%
Total operating revenue
-18.68%
Operating profit (EBIT)
-63.52%
EBITDA
-63.52%
Net Profit (Loss) for the Period
-53.3%
Total assets
-96.63%
Total equity
-76.98%
Operating Profit Margin (ROS)
-13.39%
Net Profit Margin
-13.92%
Return on Equity (ROE)
-6.71%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?